Literature DB >> 2989632

Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment.

B C Yoburn, R R Goodman, A H Cohen, G W Pasternak, C E Inturrisi.   

Abstract

Implantation of rats with prolonged-release naltrexone pellets increased both morphine's analgesic potency in the tailflick assay and radiolabeled opioid binding in the brain. The increases in both radiolabeled opioid binding and morphine potency were time-dependent. Implantation for 24 hours did not increase binding, whereas increases of approximately 45% were seen following 8 days of implantation. Similarly, morphine's analgesic potency, measured as ED50 values, was increased by 50% following 8 days of exposure to naltrexone while a 24 hour exposure had no significant effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989632     DOI: 10.1016/0024-3205(85)90322-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Involvement of mu-opioid receptors in the antitussive effects of pentazocine.

Authors:  J Kamei; K Katsuma; Y Kasuya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

2.  Increased sensitivity to rate-altering and discriminative stimulus effects of morphine following continuous exposure to naltrexone.

Authors:  A M Young; S R Mattox; M D Doty
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action.

Authors:  Jin Xu; Ming Xu; Taylor Brown; Grace C Rossi; Yasmin L Hurd; Charles E Inturrisi; Gavril W Pasternak; Ying-Xian Pan
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

4.  Regulation of dynamin 2 and G protein-coupled receptor kinase 2 in rat nucleus accumbens during acute and repeated cocaine administration.

Authors:  Joseph A Schroeder; Mary R McCafferty; Ellen M Unterwald
Journal:  Synapse       Date:  2009-10       Impact factor: 2.562

5.  Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal Volunteers.

Authors:  James W Cornish; David Henson; Sanford Levine; Joseph Volpicelli; Charles E Inturrisi; Byron C Yoburn; Charles P O'Brien
Journal:  Am J Addict       Date:  1993

6.  The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice.

Authors:  J Kamei; N Kawashima; Y Iwamoto; T Suzuki; H Nagase; M Misawa; Y Kasuya
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Chronic naltrexone suppresses platelet aggregation induced by adrenaline and 5-hydroxytryptamine in former heroin addicts.

Authors:  J A García-Sevilla; I Ulibarri; M T Giralt; P Areso; R G Oliveros; M Gutiérrez
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

8.  Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.

Authors:  Waleed O Farid; Andrew J Lawrence; Elena V Krstew; Robert J Tait; Gary K Hulse; Sarah A Dunlop
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.